DGAP-CMS: QIAGEN N.V.: Release of a capital market information

2020. november 24., kedd, 10:46







DGAP Post-admission Duties announcement: QIAGEN N.V.


/ Share Repurchase






QIAGEN N.V.: Release of a capital market information








24.11.2020 / 10:46



Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.


The issuer is solely responsible for the content of this announcement.




Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 in conjunction with Article 2 Section (2) and (3) of the Delegated EU Regulation 2016/1052 / Share Repurchase - Interim Reporting



With disclosure dated November 11, 2020, QIAGEN N.V. announced pursuant to Article 5 Section (1) and (6) of the EU Regulation no 596/2014 and Article 2 Section (1) of the Delegated EU Regulation no 2016/1052 the immediate beginning of the share repurchase program of up to USD 100 million originally announced on May 6, 2019.



The number of shares which have been bought back on the electronic trading platform of the Frankfurt Stock Exchange (XETRA) within the framework of such share repurchase program in the time period from November 16, 2020 until and including November 20, 2020 amounts to 437,553 shares.



Shares were bought back as follows:































Date Number of Shares acquired Average Price (EUR) Purchased Volume (EUR)
16 November 2020 138,196 39.3416 5,436,851.75
17 November 2020 166,722 39.0800 6,515,495.76
18 November 2020 69,533 39.5226 2,748,915.40
19 November 2020 40,000 39.6223 1,584,892.00
20 November 2020 23,082 40.0240 923,833.97
Total 437,553 39.3324 17,209,988.88

 

The underlying individual trades are published on the website of QIAGEN N.V. (http://corporate.qiagen.com/investor-relations/share-information/share-buyback).



The total number of shares which have already been bought back within the framework of the share repurchase program from November 11 until and including November 20 is 628,755 shares.



The purchase of the shares of QIAGEN N.V. was carried out by a financial institution that has been commissioned by QIAGEN N.V.



Venlo, 24 November 2020



Managing Board



###
Contacts:



QIAGEN















Investor Relations   Public Relations  
John Gilardi +49 2103 29 11711 Dr. Thomas Theuringer +49 2103 29 11826
e-mail: ir@qiagen.com   e-mail: pr@qiagen.com  














24.11.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de













Language: English
Company: QIAGEN N.V.

Hulsterweg 82

5912 PL Venlo

Netherlands
Internet: www.qiagen.com





 
End of News DGAP News Service





1150196  24.11.2020 



fncls.ssp?fn=show_t_gif&application_id=1150196&application_name=news&site_id=geo_holding_tug
Tilos a hír bármilyen adatbázisba történő mentése vagy annak továbbítása harmadik fél számára;kereskedelmi viszonylatban vagy kereskedelmi céllal csak a Deutsche Gesellschaft für Ad-hoc-Publizität mbh írásos engedélyével történhet.

Közzétételek - archívum